Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Capital in Excess of Par
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2017   1,459 20,183 [1]    
Beginning balance at Dec. 31, 2017 $ 1,855,966 $ 15 $ 2,018 $ 2,181,359 $ (327,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 300,360       300,360
Shares issued pursuant to employee benefit plans (in shares) [1]     4    
Shares issued pursuant to employee benefit plans 533     533  
Restricted stock (in shares) [1]     40    
Restricted stock 7,656   $ 5 7,651  
Common stock issued (in shares) [1]     2,530    
Common stock issued 287,988   $ 253 287,735  
Preferred stock dividend (7,295)       (7,295)
Loss on redemption of preferred stock 0        
Ending balance (in shares) at Dec. 31, 2018   1,459 22,757 [1]    
Ending balance at Dec. 31, 2018 2,445,208 $ 15 $ 2,276 2,477,278 (34,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 67,928       67,928
Shares issued pursuant to employee benefit plans (in shares) [1]     2    
Shares issued pursuant to employee benefit plans 154     154  
Restricted stock (in shares) [1]     79    
Restricted stock 11,630   $ 8 11,622  
Common stock issued (in shares) [1]     16,821    
Common stock issued 765,373   $ 1,682 763,691  
Issuance of common stock warrants 10,029     10,029  
Preferred stock dividend (3,997)       (3,997)
Preferred stock redemption (in shares)   (1,459)      
Preferred stock redemption (64,713) $ (15)   (64,698)  
Loss on redemption of preferred stock (8,304)       (8,304)
Ending balance (in shares) at Dec. 31, 2019   0 39,659 [1]    
Ending balance at Dec. 31, 2019 3,223,308 $ 0 $ 3,966 3,198,076 21,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (2,533,621)       (2,533,621)
Restricted stock (in shares) [1]     100    
Restricted stock 12,223   $ 10 12,213  
Reverse Stock Split, Value 0   $ (3,578) 3,578  
Loss on redemption of preferred stock 0        
Issuance of common stock warrants 9,109     9,109  
Other (17)     (17)  
Ending balance (in shares) at Dec. 31, 2020   0 39,759 [1]    
Ending balance at Dec. 31, 2020 $ 711,002 $ 0 $ 398 $ 3,222,959 $ (2,512,355)
[1] All share amounts have been retroactively adjusted for the Company’s 1-for-10 reverse stock split effective August 7, 2020. See “Note 11 – Stockholders’ Equity” for additional information.